The writing group has considered the rapid development of new treatments and technologies and addressed the following topics: diagnosis, aims of management, schedule of care, diabetes self-management education and support, glucose monitoring, insulin therapy, hypoglycaemia, behavioural considerations, psychosocial care, diabetic ketoacidosis, pancreas and islet transplantation, adjunctive therapies, special populations, inpatient management and future perspectives
Glycine combinations and tirzepatide glycine blends may support metabolic function
Potential Interactions Between GLP-1 Drugs and Thyroid Conditions Understanding potential interactions between GLP-1 receptor agonists and thyroid conditions requires consideration of both pharmacological mechanisms and clinical monitoring implications
26 According to a manufacturer press release, the FDA review for the MACE indication is expected to be completed in the first quarter of 2020
When weight falls quickly, those compartments lose volume faster than the overlying skin can fully retract
People with Type 2 Diabetes: GLP1 receptor agonists improve insulin secretion and lower glucagon levels, making them highly effective for managing blood sugar
